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Objective: The objective of the present study was to assess prospectively whether serial Duplex examination was useful 
in identifying impending failure after endovascular interventions of the femoropopliteal rteries. 
Setting: Non-university hospital. Prospective clinical study. 
Methods: 124 Patients were successfully treated by endovascular procedures during a 5 year period. The follow-up was 
by colour-flow Duplex examination at fixed intervals. At similar intervals clinical examination, including ankle blood 
pressure measurement was performed to assess the clinical/haemodynamic status of the patients according to the SVS/NA- 
ISCVS guidelines. For the diagnosis of impending failure the Duplex criterion was a peak systolic velocity ratio > 2.5 and 
the clinical/haemodynamic criterion was a level < + 2. Actual failure of the vascular procedure was defined as the 
occurrence of an occlusion in the treated arterial segment or a recurrent stenosis causing symptoms severe nough to require 
a reintervention. No prophylactic reinterventions were performed on the basis of abnormal Duplex findings alone. 
Results: Abnormal Duplex findings indicating restenosis were observed in 52 patients. Duplex abnormalities predicted 
treatment failure with a sensitivity of 86% and a specificity of 75%, while clinical/haemodynamic assessment had a 
sensitivity of 93% and a specificity of 90%. The hypothetical management outcome if Duplex surveillance had been used 
as a basis for reintervention was assessed. It appeared that only one patient with failure would have received a redo 
endovascular procedure at the time he had a restenosis. 
Conclusions: Clinical/haemodynamic assessment was more useful for the follow-up of endovascular interventions than 
Duplex surveillance. 
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Introduction 
Vascular laboratory surveillance has been demon- 
strated to predict and avert vein graft failure. The 
basis of surveillance by serial Duplex scanning is to 
identify stenoses before they progress to complete 
graft occlusion. Similarly, in endovascular treatment of
femoropopliteal disease recurrent stenotic lesions are 
supposedly easier to treat and may have better early 
results than occlusions. 1 It may therefore be preferable 
to diagnose a restenosis before it comes to a reocclu- 
sion in patients who have had balloon angioplasty or 
other endovascular treatment. 
The authors recently described the outcome of 
endovascular treatment of 73 patients with primarily 
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stenotic femoropopliteal lesions and 62 patients with 
femoropopliteal occlusions. 2"3 Of this cohort 124 
patients had a technical successful procedure and all 
took part in a prospective Duplex surveillance study 
during their follow-up. The purpose of the present 
paper was first to study changes indicating the rate of 
restenosis with Duplex testing of the treated segments 
during follow-up; second to assess whether these 
findings can be used to diagnose impending failure, 
and third whether Duplex surveillance did improve 
on the predictive value of conventional clinical follow- 
up, making it worthwhile for routine follow-up of 
endovascular p ocedures. 
Patients and Methods 
One hundred and twenty-four patients with femoro- 
popliteal obstructive lesions were recruited from 
January 1988 to July 1993. Only patients with a 
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successful endovascular procedure were studied. Eli- 
gible patients included those with intermittent claudi- 
cation of at least 3 months duration and obstructive 
lesions of the femoropopliteal rteries that appeared 
suitable for an endovascular p ocedure. Only one limb 
per patient was studied. Preinterventional assessment 
included physical examination, determination of 
ankle-brachial blood pressure index (ABI) and an 
arteriogram. 
At the start of the procedure 5000 units of Heparin 
were given intra-arterially. Seventy-one of the patients 
with a stenosis underwent a balloon angioplasty (35) 
or an atherectomy (36) and 53 patients with an 
occlusion underwent a recanalisation combined with a 
balloon angioplasty (49) or an atherectomy (4). All 
patients gave consent for regular colour-Duplex stud- 
ies during follow-up. Post-procedure monitoring 
included peripheral pulse palpation and ankle pres- 
sure measurements. Patients were routinely dis- 
charged the second day after the procedure. Eighty 
milligrams of Aspirin orally was prescribed in all 
patients tarting at least I day prior to the intervention 
and was continued indefinitely thereafter. 
Methods of follow-up 
Follow-up included pulse palpation, determination of
the ABI and post-exercise ankle blood pressure (AP), 
and colour-Duplex investigations every 3 months 
during the first year, at 6 monthly intervals during the 
second year and once a year thereafter. In addition, 
these examinations were done when recurrent symp- 
toms occurred. In patients with significant worsening 
of intermittent claudication and worsening of the 
ankle pressure parameters, an arteriogram was per- 
formed at the time of their symptoms when their 
complaints were severe enough to consider a 
reintervention. 
Colour-Duplex scanning was performed using a 
Quantum Angio-dynograph® (Philips Medical Sys- 
tems). During the examination, the entire femor- 
opopliteal segment was investigated from the groin to 
the popliteal trifurcation. Stenotic segments were 
identified by locally increased velocities and post- 
stenotic turbulence. The degree of restenosis was 
assessed on the basis of the ratio of the increased peak 
systolic velocity at the side of the stenosis and the 
peak systolic velocity of a nearby normal arterial 
segment (PSV-ratio). Reocclusion was characterised by 
the absence of detectable Doppler signals at the 
treated segments, tissue bruits and increased collateral 
flow. Although colour-Duplex enables differentiation 
between true recurrent disease at the site of the initial 
treatment and new disease in non-treated segments, in
this study we did not distinguish between these two 
conditions. From our previous tudies, using the same 
patient material it was apparent hat isolated new 
lesions comprised only a very small proportion of all 
identified late disease. 2'3 
Definitions, endpoints and statistical analysis 
The procedure was defined technically successful if
there was a completed recanalisation and dilatation. 
At follow-up the clinical/haemodynamic improve- 
ment status was assessed using the Society for 
Vascular Surgery and the International Society for 
Cardio-Vascular Surgery (SVS/ISCVS) scale of post- 
procedural improvement. 4 This scale ranges from -3 
for severe worsening to + 3 for normalisation of the 
ABI and post-exercise (AP) together with disap- 
pearance of symptoms. A scale of + 2 corresponds to 
an improvement of the ABI, although no normal- 
isation, and a post-exercise AP of at least 25 to 50 
mmHg below the systolic arm blood pressure. 
Impending failure was defined as a change of 
clinical/haemodynamic status to a grade less than + 2. 
At colour-Duplex impending failure was defined as a 
PSV-ratio > 2.5. Actual failure was defined as complete 
occlusion or a reintervention for restenosis. Occlusion 
was diagnosed by colour-Duplex or by arteriography. 
To determine the predictive value of the two indices, 
clinical/haemodynamic status and colour-Duplex 
assessment, great care was given to distinguish 
parameters measured at the time of impending failure 
and at actual failure. 
Agreement of colour-Duplex abnormalities and 
positive clinical/haemodynamic testing vs. the occur- 
rence of late failure was assessed by a dichotomous 
approach, i.e. calculating sensitivity, specificity and 
positive and negative predictive values (PPV and 
NPV). In addition, cumulative-frequency distribution 
curves of the PSV ratio values were constructed. In 
this method the values are viewed as a continuous 
variable as opposed to the dichotomous approach. 5 
Results 
Patients, lesion characteristics and early results 
Clinical characteristics, prevalence of risk factors, 
associated iseases and lesion characteristics are sum- 
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Table 1. Clinical characteristics, risk factors and angiographic 
baseline data in 124 patients with colour-Duplex surveillance afteI 
endovascular treatment of femoropopliteal lesions 
No. of patients 
Age (years), median (range) 46 (46~0) 
Sex ratio (M:F) 94:30 
Diabetes mellitus 21 




Coexisting stenoses 36 
2-3 open crural vessels 103 
0-1 open crural vessels 21 
marised in Table 1. Coexisting stenoses of less severity 
were observed in 36 patients and were treated 
simultaneously. It should be noted that the patients in 
this study comprised primarily a favourable group, as 
there were only claudicants and good run off was 
observed in 103. The median length of the lesions was 
2.3cm (range 0.5 to 15). In 102 of the patients the 
lesions were located in the 3rd or the 4th segment of 
the superficial femoral artery, the first or the second 
segment was involved in nine patients and the first 
popliteal segment in 13. In none of the patients the 
below-knee popliteal artery was involved. 
Only patients with a technical successful procedure 
were recruited for this study (124 patients). Nine 
patients had a residual stenosis of 30-50% in diameter 
reduction and one patient had a 60% residual stenosis. 
Small dissections were observed in six patients and in 
one a large dissection. One patient had an acute 
thrombosis of the treated segment but this condition 
could successfully be managed by thrombolysis. 
These events were not considered to be serious 
complications as all patients had an open treatment 
site at discharge. 
ClinicaI/haemodynamic results 
Seventeen patients experienced no improvement or 
only minimal improvement (grade + 1 or less) at 1 
month after the procedure. A moderate improvement 
(grade + 2) was observed in 23 and normalisation 
(grade + 3) in 84 patients representing a favourable 
result in 86%. After the procedure the median rise of 
the ABI was 0.22 (range -0.20 to 0.76) and the median 
post-exercise ankle blood pressure was 104 mmHg 
(range 40 to 240). The ABI was not recorded in three 
patients owing to incompressible crural vessels and 
the postexercise ankle pressure was not measured in 
an additional 10 patients, because of their inability to 
perform the treadmill test. In these 13 patients the 
improvement s atus was assessed on the basis of their 
symptoms and/or the return of arterial pulses at the 
foot and resting ABI if available. 
At follow-up the clinical/haemodynamic status was 
abnormal (level + 1 or less) in 46 patients. During the 
subsequent course of these patients failure of treat- 
ment was diagnosed by colour-Duplex or angiog- 
raphy in 38 (83%), because of occlusion in 14 and 
because of endovascular intervention for restenosis in 
24 patients. In eight (17%) of the patients with a 
deteriorated clinical/haemodynamic classification the 
Duplex-anatomic status of the femoropopliteal rterial 
system remained stable without occlusion for a 
median of 21 months (range 4 to 45). If there were 
recurrent symptoms but no reinterventions, this was 
usually because the patient and the physician agreed 
on a conservative policy. 
Colour-Duplex surveillance and its comparison with 
clinical/haemodynamic follow-up 
The mean number of Duplex examinations performed 
until an endpoint of primary patency was reached, 
was 2.7 per patient (range I to 8). The median duration 
of follow-up was 16 months (range 0 to 60). Five 
patients were excluded from the following analysis 
because an occlusion occurred within the first month 
after treatment before a colour-Duplex scan was 
performed. Abnormal colour-Duplex findings indicat- 
ing recurrent stenotic disease were observed in 52 
patients. In Fig. 1 the cumulative-frequency distribu- 
tion curves of observed PSV ratios in patients with 
and without actual late failure are represented. At 3 
months PSV ratios in the group with late failure 
appeared higher than in the category with continued 
patency with values greater than 2.5 in 31% of patients 
in the first category and in 7% in the latter category 
(Fig. la and b). At late follow-up examinations the 
differences between patient groups became much 
more pronounced, with PSV ratios indicating sig- 
nificant restenoses observed in 94% of the patients 
with late failure and in 26% of the patients with 
durable success. In the former group the mean interval 
between the procedure and the time that the highest 
PSV ratios were identified was 8 months, while at 12 
months in 81% of these patients the PSV ratio was > 
2.5. 
In the 52 patients with a positive Duplex scan failure 
of the procedure occurred in the later follow-up course 
in 31 (60%), of which eight progressed their recurrent 
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lesions to occlusions and 23 had a reintervention 
because of a symptomatic restenosis. 21 (40%) Patients 
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Fig. 1. Cumulative-frequency distribution curves show percentage 
of patients with given PSV ratios at 3 months (First Duplex) and at 
time of highest observed PSV ratio during follow-up (Last Duplex). 
Value on ordinate represents percent of patients with PSV ratios 
greater than corresponding value on abscissa. Starting at a normal 
level of approximately 1.0, a large majority of patients have greater 
PSV ratios. (A) Graphs of patients with continued patency at follow- 
up. (B) Graphs of patients with late failure (occlusion or reinterven- 
tion for significant stenosis). Last Duplex values represent he 
measurements before failure. Vertical interrupted lines indicate the 
threshold value of significant restenosis. ( - - - )  First Duplex; ( - - - - )  
Last Duplex. 
Duplex scanning during a median follow-up of 19 
months (range 4 to 56). 
Duplex measurements and clinical/haemodynamic 
status were assessed as simple indicators of impend- 
ing failure (Table 2). The agreement of the clinical/ 
haemodynamic assessment with late failure was better 
than that of Duplex. However, it should be remem- 
bered that the decision to reintervene was a clinical 
one, based on symptoms and this might have skewed 
the correlation in favour of the clinical/haemody- 
namic assessment. Therefore, the correlation between 
the indices and subsequent occlusion, which is of 
course independent of any clinical decision making, 
was assessed as well. Again clinical/haemodynamic 
evaluation had a superior correlation with occlusion 
as compared with serial Duplex testing. 
Retrospective evaluation of the consequences of late 
occlusion 
The clinical records, Duplex and arteriographic data of 
the eight patients that had an occlusion in the presence 
of a positive Duplex scan were re-evaluated at the 
time of this analysis to determine whether these latter 
patients might have missed an opportunity for secon- 
dary endovascular treatment. Subsequent surgical 
treatment was required in only two patients, redo 
endovascular t eatment was performed in two and 
four patients were treated conservatively. In theory the 
two surgical reconstructions and four conservative 
treatments could have been prevented if active treat- 
ment on the basis of a positive Duplex scan had been 
our policy. However, seven of the eight patients with 
significant restenoses on Duplex had a positive clin- 
ical/haemodynamic classification as well before they 
occluded their treatment site. Thus in this complete 
series primary reliance on colour-Duplex hypothet- 
ically might have prevented only one patient from 
occlusion by redo endovascular intervention. 
Table 2. Value of colour-Duplex and c l in ica l /haemodynamic lassification as indices for late arterial failure (occlusion or reintervenfion 
for stenosis) and late arterial occlusion 
Positive Sensitivity Specificity PPV NPV 
criterion n (%) n (%) n (%) n (%) 
Colour-Duplex* vs.  failure 
Clinical/haemodynamic assessment vs. failure 
Colour-Duplex* vs.  occlusion 
Clinical/haemodynamic assessment vs. occlusion 
PSV ratio > 2.5 31/36 (86) 62/83 (75) 31/52 (60) 62/67 (92) 
Level < + 2 38/41 (93) 75/83 (90) 38/46 (83) 75/78 (96) 
PSV ratio > 2.5 8/12 (67) 62/83 (75) 8/29 (28) 62/66 (94) 
Level < + 2 14/17 (82) 75/83 (90) 14/22 (64) 75/78 (96) 
*PSV ratios of five patients without duplex assessment before arterial occlusion (all within 3 months) were not considered; PPV, positive 
predictive value; NPV negative predictive value; PSV ratio, peak systolic velocity ratio. 
Eur J Vasc Endovasc Surg Vol 12, August 1996 
Duplex Surveillance 149 
Discussion 
Several investigators have observed that Duplex 
derived PSV-ratios accurately reflect the anatomic 
status of the arterial tree. 7-1° Therefore, in the present 
study serial colour-Duplex assessment was used to 
investigate the tendency of restenosis and occlusion 
development in the femoropopliteal system after 
recanalisation of angioplasty. One of the aspects was 
to assess the outcome of Duplex examinations at 3 
months and at the time that the highest PSV-ratio was 
measured in a cumulative frequency distribution 
graph. The highest PSV-ratios were observed at a 
mean of 8 months, following the procedure. This 
approach was used to compare two groups: (1) 
patients with late failure, and (2) patients with a 
durable success. It appears that, at the first examina- 
tion, the group with late failure already had abnormal 
Duplex findings in 31%, suggesting a smaller diameter 
at the treatment site. Over time a significant restenosis 
developed in 94% of these patients, while in contrast, 
there was only a luminal loss of modest proportion in 
the group with continued patency. These findings 
suggested that the majority of recurrent lesions devel- 
oped between 3 and 12 months. These observations 
differ from those of Kinney et al. who suggested that 
inadequate treatment might be responsible for a 
substantial proportion of late recurrences. 1~This dif- 
ference may be explained by a lower rate of residual 
stenoses in the present study, as completion arteriog- 
raphy demonstrated a residual stenosis in only 10 
(8%), while in the study of Kinney et al. a residual 
stenosis rate was reported in 1/3 of successful 
procedures. Our findings suggested that progression 
of stenoses was more important han residual esions 
in the development of recurrent disease. 
The effectiveness of Duplex surveillance following 
veingrafts for femorodistal obstructive disease in 
improving long-term results has convincingly been 
demonstrated. ~2-14 The basic principle of this 
approach is the identification of preocclusive l sions 
allowing correction by minor revisions. It was specu- 
lated that after endovascular procedures the identi- 
fication of recurrent stenoses also may be of advan- 
tage. Balloon angioplasty of stenotic lesions is 
associated with a higher procedural success rate as 
well as with better long-term patency than the 
15 17 recanalisation of occlusions. - Similarly in recurrent 
disease, stenoses are supposed to respond better to 
redo balloon dilatation than complete occlusions. 1 
Despite these considerations a comprehensive evalua- 
tion of the effectiveness of Duplex compared to clinical 
follow-up has not been reported before. 
In the present analysis abnormal findings at colour- 
Duplex scanning correlated with impending failure, 
either by late occlusion or by reintervention, in 60% of 
the patients. Despite Duplex evidence of restenosis 
40% maintained patency of the femoropopliteal sys- 
tem. In comparison, a poor clinical/haemodynamic 
status ( < + 2) predicted failure in 83%, while only 17% 
of these patients maintained patency. In the overall 
patient group the sensitivity of the colour-Duplex for 
impending failure was 86% and the specificity 75%, 
while the overall sensitivity of clinical/haemody- 
namic assessment was 93% and the specificity 90%. 
Thus, contrary to our expectations these findings 
demonstrated that colour-Duplex surveillance was not 
as reliable as a strict clinical/haemodynamic assess- 
ment protocol in predicting subsequent failure. This 
could not be explained by the fact that reinterventions, 
which made up part of the failures, were performed 
on the basis of symptoms rather than on the outcome 
of non-invasive measurements. In a separate correla- 
tion, late occlusion, as a factor independent of any 
clinical decision making, was predicted with greater 
accuracy by clinical/haemodynamic status as well. 
This study differs in design from previous reports 
that have compared clinical evaluation, ABI determi- 
nation and Duplex parameters with a significant 
angiographic stenosis (>50% diameter reduction) 
after endovascular procedures. 11"1B-2° These studies 
concluded that Duplex scanning was more accurate 
than clinical assessment, in identifying restenoses. 11'2° 
The present study appraises the predictive value for 
late failure, combining occlusions and the need for 
reinterventions, rather than the diagnostic agreement 
with angiography. 
It may be argued that colour-Duplex provides 
accurate anatomic and physiologic information and is 
therefore more objective than a classification compris- 
ing symptoms and ABI. Kinney et al. suggested that 
the application of Duplex follow-up of endovascular 
procedures hould be expanded, as they found ABI 
determination insufficiently accurate to distinguish 
between a recurrent stenosis and progression of 
disease in untreated areas. ~1 In contrast, Miller et al. 
designated Duplex mainly useful as an investigative 
18 tool. In their study all restenoses, which ultimately 
progressed to occlusion, were first disclosed by a 
decrease of segmental limb pressures. In addition, 
Walsh et al. demonstrated, in a study of untreated 
superficial femoral stenoses, that progression usually 
is associated with synchronous ymptomatic deteri- 
oration. 21 In the present stud~ when evaluation of 
possible management outcome if colour-flow Duplex 
had been used to as a basis to perform a reinterven- 
tion, at best one patient would have received a redo 
endovascular procedure. These findings suggest hat 
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routine Duplex surveillance may be unnecessary and 
risks treating lesions rather than patients. In conclu- 
sion, failure of endovascular treatment is usually 
preceded by a restenosis. Although colour-Duplex can 
demonstrate r stenotic lesions, careful clinical/hae- 
modynamic assessment is the best method for follow- 
up.  
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